Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.
Also called NCT03044184
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 220 participants
- Sponsor
- Kwong Wah Hospital
- Registry
-
NCT03044184
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Unknown status
Technical summary
Registry record NCT03044184. Randomized; double masking; primary purpose treatment. Start 2017-04-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
- Acronym
- TRANSACT
- Condition
- Stroke Hemorrhagic
- Condition
- Intracerebral Haemorrhage
- Intervention (Drug)
- Tranexamic Acid
- Lead sponsor
- Kwong Wah Hospital
Record details
- Record id
cardio:ct-nct03044184- Content hash
9b2424d586689f3908765b4b764d704e50471df13386f1d2a7d804605fe5529a